The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Vanda Pharmaceuticals Inc

Nasdaq: VNDA
Last

(U.S.) $14.05

Today's change0.00 0.00%
Updated May 26 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Vanda Pharmaceuticals Inc

Nasdaq: VNDA
Last

(U.S.) $14.05

Today's change0.00 0.00%
Updated May 26 4:00 PM -4GMT. Delayed by at least 15 minutes.

Vanda Pharmaceuticals Inc closed at (U.S.)$14.05.

Over the last five days, shares have lost 1.40% and are down 11.91% for the last year to date. This security has outperformed the S&P 500 by 32.47% during the last year.

Key company metrics

  • Open(U.S.) $14.30
  • Previous close(U.S.) $14.05
  • High(U.S.) $14.50
  • Low(U.S.) $13.95
  • Bid / Ask(U.S.) $13.50 / (U.S.) $0.00
  • YTD % change-11.91%
  • Volume440,081
  • Average volume (10-day)396,660
  • Average volume (1-month)457,547
  • Average volume (3-month)547,112
  • 52-week range(U.S.) $9.47 to (U.S.) $18.00
  • Beta1.47
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.30
Updated May 26 4:00 PM -4GMT. Delayed by at least 15 minutes.

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue37383836
Total other revenue--------
Total revenue37383836
Gross profit33333130
Total cost of revenue4576
Total operating expense45393941
Selling / general / administrative30242225
Research & development11877
Depreciation / amortization0233
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-8-1-1-5
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-8-10-5
Income after tax-8-10-5
Income tax, total00----
Net income-8-10-5
Total adjustments to net income--------
Net income before extra. items-8-10-5
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-8-10-5
Inc. avail. to common incl. extra. items-8-10-5
Diluted net income-8-10-5
Dilution adjustment--------
Diluted weighted average shares44444443
Diluted EPS excluding extraordinary itemsvalue per share-0.17-0.01-0.01-0.11
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.17-0.01-0.01-0.11